| [1] |
Forrester SN, Gallo JJ, Smith GS, et al. Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia[J]. Am J Geriatr Psychiatry, 2016, 24(2):117-125.
|
| [2] |
Pollak CP, Perlick D. Sleep problems and institutionalization of the elderly[J]. J Geriatr Psychiatry Neurol, 1991, 4(4):204-210.
|
| [3] |
Hebert LE, Weuve J, Scherr PA, et al. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census[J]. Neurology, 2013, 80(19):1778.
|
| [4] |
Ancoli-Israel S, Klauber MR, Butters N, et al. Dementia in institutionalized elderly: relation to sleep apnea[J]. J Am Geriatr Soc, 1991, 39(3):258-263.
|
| [5] |
Guarnieri B, Adorni F, Musicco M, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients[J]. Dement Geriatr Cogn Disord, 2012, 33(1):50-58.
|
| [6] |
Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology--a bidirectional relationship[J]. Nat Rev Neurol, 2014, 10(2):115-119.
|
| [7] |
de Almondes KM, Costa MV, Malloy-Diniz LF, Diniz BS. Insomnia and risk of dementia in older adults: Systematic review and meta-analysis[J]. J Psychiatr Res, 2016, 77:109-115.
|
| [8] |
Osorio RS, Pirraglia E, Gumb T, et al. Imaging and cerebrospinal fluid biomarkers in the search for Alzheimer's disease mechanisms[J]. Neurodegener Dis, 2013, 13(2-3):163-165.
|
| [9] |
Farnoosh E, Habibolah K, Masoud T, et al. The Association between obstructive sleep apnea and Alzheimer's disease: A Meta-analysis perspective[J]. Front Aging Neurosci, 2016, 8:78.
|
| [10] |
Kadotani H, Kadotani T, Young T, et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults[J]. JAMA, 2001, 285(22):2888-2890.
|
| [11] |
Andrew SPL, Kowgier M, Yu L, Buchman AS, et al. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons[J]. Sleep, 2013, 36(7):1027-1032.
|
| [13] |
Yaffe K, Nettiksimmons J, Yesavage J, et al. Sleep quality and risk of dementia among older male veterans[J]. Am J Geriatr Psychiatry, 2015, 23(6):651-654.
|
| [14] |
Mecca AP, Michalak HR, McDonald JW, et al. Sleep disturbance and the risk of cognitive decline or clinical conversion in the adni cohort[J]. Dement Geriatr Cogn Disord, 2018, 45(3-4):232-242.
|
| [15] |
Bliwise DL, Foley DJ, Vitiello MV, et al. Nocturia and disturbed sleep in the elderly[J]. Sleep Med, 2009, 10(5):540-548.
|
| [16] |
Endeshaw YW, Schwartz AV, Stone K, et al. Nocturia, insomnia symptoms and mortality among older men: The health, aging and body composition study[J]. J Clin Sleep Med, 2016, 12(6):789-796.
|
| [17] |
Talarico G, Canevelli M, Tosto G, et al. Restless legs syndrome in a group of patients with Alzheimer's disease[J]. Am J Alzheimers Dis Other Demen, 2013, 28(2):165-170.
|
| [18] |
Ohayon MM, Vecchierini MF. Daytime sleepiness and cognitive impairment in the elderly population[J]. Arch Intern Med, 2002, 162(2):201-208.
|
| [19] |
Peters ME, Rosenberg PB, Steinberg M, et al. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The Cache county study[J]. Am J Geriatr Psychiatry, 2013, 21(11):1116-1124.
|
| [20] |
Loerbroks A, Debling D, Amelang M, et al. Nocturnal sleep duration and cognitive impairment in a population-based study of older adults[J]. Intern J Geriatr Psychiatry, 2010, 25(1):100-109.
|
| [21] |
Carvalho DZ, St Louis EK, Knopman DS, et al. Association of excessive daytime sleepiness with longitudinal β-amyloid accumulation in elderly persons without dementia[J]. JAMA Neurol, 2018, 75(6):672-680.
|
| [22] |
Videnovic A, Lazar AS, Barker RA, et al. 'The clocks that time us' -Circadian rhythms in neurodegenerative disorders[J]. Nat Rev Neurol, 2014, 10(12):683-693.
|
| [23] |
Volicer L, Harper DG, Manning BC, et al. Sundowning and circadian rhythms in Alzheimer's disease[J]. Am J Psychiatry, 2001, 158(5):704-711.
|
| [24] |
Sancesario G, Sica F, Ferrazzoli D. Sundowning syndrome: A possible marker of frailty in Alzheimer's disease[J]? CNS Neurol Disord Drug Targets, 2013, 12(4):525-528.
|
| [25] |
Cricco M, Simonsick EM, Foley DJ. The impact of insomnia on cognitive functioning in older adults[J]. J Am Geriatr Soc, 2001, 49(9):1185-1189.
|
| [26] |
Pace-Schott EF, Spencer RM. Sleep-dependent memory consolidation in healthy aging and mild cognitive impairment[J]. Curr Top Behav Neurosci, 2015, 25:307-330.
|
| [27] |
Lim MM, Gerstner JR, Holtzman DM. The sleep-wake cycle and Alzheimer's disease: What do we know[J]? Neurodegener Dis Manag, 2014, 4(5):351-362.
|
| [28] |
Ju YES, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology-a bidirectional relationship[J]. Nat Rev Neurol, 2014, 10(2):115-119.
|
| [29] |
Spira AP, Gottesman RF. Sleep disturbance: an emerging opportunity for Alzheimer's disease prevention[J]? Int Psychogeriatr, 2017, 29(4):529-531.
|
| [30] |
Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle[J]. Science, 2009, 326(5955):1005-1007.
|
| [31] |
Ooms S, Overeem S, Besse K, et al. Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men: A Randomized Clinical Trial[J]. JAMA Neurol, 2014, 71(8):971-977.
|
| [32] |
Spira AP, Gamaldo AA, An Y, et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults[J]. JAMA Neurol, 2013, 70(12):1537-1543.
|
| [33] |
Niwa Y, Kanda GN, Yamada RG, et al. Muscarinic acetylcholine receptors chrm1 and chrm3 are essential for REM sleep[J]. Cell Rep, 2018, 24(9):2231-2247.
|
| [34] |
Atucha E, Vukojevic V, Fornari RV, et al. Noradrenergic activation of the basolateral amygdala maintains hippocampus-dependent accuracy of remote memory[J]. Proc Natl Acad Sci USA, 2017, 114(34):9176-9181.
|
| [35] |
Braun AA, Amos-Kroohs RM, Gutierrez A, et al. Dopamine depletion in either the dorsomedial or dorsolateral striatum impairs egocentric Cincinnati water maze performance while sparing allocentric Morris water maze learning[J]. Neurobiol Learn Mem, 2015, 118:55-63.
|
| [36] |
Leiser SC, Li Y, Pehrson AL, et al. Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: A review of individual 5-HT receptor mechanisms and concerted effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine[J]. ACS Chem Neurosci, 2015, 6(7):970-986.
|
| [37] |
Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease[J]. Exp Mol Med, 2015, 47(3):e148.
|
| [38] |
Zhou L, Gao Q, Nie M, et al. Degeneration and energy shortage in the suprachiasmatic nucleus underlies the circadian rhythm disturbance in ApoE-/- mice: implications for Alzheimer’s disease[J]. Sci Rep, 2016, 6:36335.
|
| [39] |
Bellanti F, Iannelli G, Blonda M, et al. Alterations of clock gene rna expression in brain regions of a triple transgenic model of Alzheimer's disease[J]. J Alzheimers Dis, 2017, 59(2):615-631.
|
| [40] |
Claustrat B, Leston J. Melatonin: Physiological effects in humans[J]. Neurochirurgie, 2015, 61(2-3):77-84.
|
| [41] |
Wichniak A, Jankowski KS, Skalski M, et al. Treatment guidelines for Circadian Rhythm Sleep-Wake Disorders of the Polish Sleep Research Society and the Section of Biological Psychiatry of the Polish Psychiatric Association, part I: Physiology, assessment, and therapeutic methods[J]. Psychiatr Pol, 2017, 51(5):793-814.
|
| [42] |
Shiota S, Takekawa H, Matsumoto SE, et al. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice[J]. J Alzheimers Dis, 2013, 37(2):325-333.
|
| [43] |
Dubey A, Handu S, Mediratta P. Suvorexant: The first orexin receptor antagonist to treat insomnia[J]. J Pharmacol Pharmacother, 2015, 6(2):118-121.
|
| [44] |
Liguori C, Nuccetelli M, Izzi F, et al. Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease[J]. Neurobiol Aging, 2016, 40:120-126.
|
| [45] |
Urrestarazu E, Iriarte J. Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies[J]. Nat Sci Sleep, 2016, 8:21-33.
|
| [46] |
Song HR, Woo YS, Wang HR, et al. Effect of the timing of acetylcholinesterase inhibitor ingestion on sleep[J]. Int Clin Psychopharmacol, 2013, 28(6):346-348.
|
| [47] |
García-Alberca JM, Lara JP, Cruz B, et al. Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment[J]. J Nerv Ment Dis, 2013, 201(3):251-257.
|
| [48] |
Feld GB, Wilhelm I, Ma Y, et al. Slow wave sleep induced by GABA agonist tiagabine fails to benefit memory consolidation[J]. Sleep, 2013, 36(9):1317-1326.
|
| [49] |
Shih HI, Lin CC, Tu YF, et al. An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study[J]. Medicine (Baltimore), 2015, 94(17):e809.
|
| [50] |
Walsh JK, Hall-Porter JM, Griffin KS, et al. Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss[J]. Sleep, 2010, 33(9):1217-1225.
|
| [51] |
Michelson D, Snyder E, Paradis E, et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial[J]. Lancet Neurol, 2014, 13(5):461-471.
|